InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Ege David S.. Officer active across 1 company, notably Seres Therapeutics, Inc.. In total, 7 disclosures have been recorded. Activity tracked since 5 July 2022. The latest transaction was disclosed on 27 October 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
7 of 7 declarations